Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA warns Endo Health on AMS pelvic mesh plant
Mass Device
Thursday, April 17, 2014 - 12:09pm
tags:
FDA, pelvic mesh, devices, Endo Health Solutions, American Medical Systems
AbbVie Candidate in Pivotal Study
Yahoo/Zacks.com
Thursday, April 17, 2014 - 11:51am
tags:
AbbVie, veliparib, non-small cell lung cancer
Gilead Sciences, Inc. Feeling Sovaldi Pressure From All Sides
Motley Fool
Thursday, April 17, 2014 - 11:49am
tags:
Sovaldi, hepatitis C, Gilead Sciences, AbbVie, Merck, Bristol-Myers Squibb, Express Scripts
StemCells completes enrollment in spinal cord injury trial
Yahoo/Fly on the Wall
Thursday, April 17, 2014 - 11:22am
tags:
StemCells, spinal cord injury, HuCNS-SC
Earnings Primer: What's on Deck for Amgen Inc. and Biogen Idec Inc.
Motley Fool
Thursday, April 17, 2014 - 11:19am
tags:
Amgen, Biogen Idec, earnings
Generic Drugmakers Fight Teva’s Bid to Stall Competition
Wall St Cheat Sheet
Thursday, April 17, 2014 - 10:57am
tags:
generics, Teva, Copaxone, MS, multiple sclerosis
Teva, Pfizer settle patent lawsuit over blockbuster painkiller
Yahoo/Reuters
Thursday, April 17, 2014 - 10:56am
tags:
Teva, Pfizer, patents, Celebrex
Top 10 Pharma M&A deals of 2013
Fierce Pharma
Thursday, April 17, 2014 - 8:29am
tags:
M&A, Amgen, ONYX Pharmaceuticals, Bausch & Lomb, Valeant Pharmaceuticals, Elan, Perrigo, Actavis, Warner Chilcott, Bristol-Myers Squibb, AstraZeneca, Pearl Therapeutics, Agila, Mylan, Salix, Santarus, Bayer, Algeta, Shire, ViroPharma
Dynavax initiates PhIII study it hopes will quell FDA's safety concerns
Fierce Vaccines
Thursday, April 17, 2014 - 8:26am
tags:
Dynavax, FDA, Heplisav
Industry Sees Much not to ‘Like’ in FDA's First Social Media Guidance Document
Regulatory Focus
Thursday, April 17, 2014 - 8:05am
tags:
FDA, social media
Actelion May Raise Forecast After First-Quarter Earnings
Bloomberg
Thursday, April 17, 2014 - 8:03am
tags:
Actelion, earnings
The Biggest Biotech Wins of the Week
Motley Fool
Thursday, April 17, 2014 - 7:46am
tags:
biotech, Puma Biotechnology, aripiprazole lauroxil, Alkermes, neratinib, Roche, Herceptin, bemaciclib, breast cancer, Eli Lilly
GSK, facing bribery claims, battles to build new sales model
Reuters
Thursday, April 17, 2014 - 7:44am
tags:
GSK, bribery, physicians
GSK says investigating claims of bribery in Jordan, Lebanon
Reuters
Thursday, April 17, 2014 - 7:43am
tags:
GSK, bribery, Jordan, Lebanon
New kind of trial aims to speed cancer drug development
Yahoo/Reuters
Thursday, April 17, 2014 - 7:42am
tags:
clinical trials, drug development, cancer, Pfizer, AstraZeneca
Gilead Sciences May See A Healthy Earnings Beat
Seeking Alpha
Wednesday, April 16, 2014 - 5:18pm
tags:
earnings, Gilead Sciences
Cancer Doctors Plan to Compare Value of Expensive Drugs
Bloomberg
Wednesday, April 16, 2014 - 5:17pm
tags:
cancer, physicians, ASCO
St. Jude Medical (STJ) Stock Down Despite Positive Earnings Report
TheStreet.com
Wednesday, April 16, 2014 - 5:09pm
tags:
St. Jude Medical, devices, earnings
Edwards Says Medtronic’s CoreValve Shouldn’t Be Banned in U.S.
Bloomberg
Wednesday, April 16, 2014 - 5:07pm
tags:
Medtronic, CoreValve, devices
Rumor Mill: Is Google working on contact lenses for the blind?
Mass Device
Wednesday, April 16, 2014 - 10:59am
tags:
Google, devices, blindness

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.